{
"NDC": {
"NDCCode": "73207-101-30",
"PackageDescription": "1 BOTTLE in 1 CARTON (73207-101-30) / 90 TABLET in 1 BOTTLE",
"NDC11Code": "73207-0101-30",
"ProductNDC": "73207-101",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Qinlock",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Ripretinib",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20200515",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA213973",
"LabelerName": "Deciphera Pharmaceuticals, LLC",
"SubstanceName": "RIPRETINIB",
"StrengthNumber": "50",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Kinase Inhibitor [EPC], P-Glycoprotein Inhibitors [MoA], Platelet-derived Growth Factor alpha Receptor Inhibitors [MoA], Stem Cell Factor (KIT) Receptor Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-05-13",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20200515",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}